Dr. Qiang Liu
Viral Pathogenesis & Vaccine Development
Dr. Qiang Liu's research is on elucidating molecular mechanisms of viral pathogenesis. Special research areas are human hepatitis viruses including hepatitis C virus and hepatitis B virus. He received his BSc and MSc degrees at Nankai University in China and PhD at Justus Liebig University in Germany. Dr. Liu is an adjunct professor at the Department of Veterinary Microbiology and the Department of Pathology and Laboratory Medicine. He is an associate member of the Biomedical Engineering Division, College of Engineering. In addition, Dr. Liu is a mentor of the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC).
Qiang Liu, Ph.D.
♦ Member, College of Graduate Studies and Research, University of Saskatchewan
♦ Member, VIDO-InterVac Local Safety Committee
♦ Adjunct Professor, Departments of Pathology and Laboratory Medicine and Veterinary Microbiology
♦ M.Sc. and B.Sc., Microbiology, Nankai University, Tianjin, China
♦ Identification of a unique amino acid residue of HCV-3a core protein essential for modulating lipogenic gene expression
♦ Identification of the role of the PI3K-Akt-2 pathway in SREBP-1 activation by HCV
♦ Development of a novel experimental system for studying HCV protein translation
CURRENT RESEARCH AREAS
♦ Signal transduction pathways regulating HCV pathogenesis
♦ Host and viral factors modulating HCV protein translation
♦ Synergistic pathogenesis of HBV and HCV